Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eli Lilly
Biotech
Lilly pads oral GLP-1 case with pair of phase 3 diabetes wins
Lilly's oral GLP-1 drug candidate racked up wins against placebo and AZ's Farxiga to stay on track to seek approval in Type 2 diabetes next year.
Nick Paul Taylor
Oct 15, 2025 9:48am
Roche nabs FDA clearance for Alzheimer's biomarker blood test
Oct 14, 2025 11:12am
Former CBER chief Peter Marks leaps to Lilly—Chutes & Ladders
Oct 10, 2025 8:30am
Former FDA official Peter Marks joins Eli Lilly
Oct 7, 2025 3:49pm
Lilly calls for improvements to Alzheimer's testing in Europe
Oct 7, 2025 9:30am
Eli Lilly opens latest incubator site in San Diego
Sep 26, 2025 9:55am
